Drug Database
Back to search

Belgium· BE-AMP-SAM153937-00

Alomide 1.78 mg/ml

A lodoxamide product containing lodoxamide tromethamine, registered in Belgium by Novartis Pharma. The same ATC class is registered in 4 of our 19 countries.

ATC S01GX05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAlomide 1.78 mg/mlATCS01GX05REGISTER NO.BE-AMP-SAM153937-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lodoxamide tromethamineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lodoxamide is registered in 4 of 19 countries.

Countries holding a registration under ATC S01GX05 (lodoxamide), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 2 of them publish a price we can compare per daily dose
Search lodoxamide products by name

Lodoxamide · ATC S01GX05

4 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Lodoxamide Tromethamine
Manufacturer
Novartis Pharma
Country
Belgium (BE)
ATC code
S01GX05
ATC class
Lodoxamide
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    0245795

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lodoxamide in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lodoxamide products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Finland · Alomide
  • United Kingdom (Northern Ireland) · Alomide
  • Hungary · Alomide
  • Luxembourg · Alomide

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b58cc993-f98b-4271-8952-a68e1a24dac2
GET /v1/drugs/b58cc993-f98b-4271-8952-a68e1a24dac2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Eye drops, solution",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Alomide 1.78 mg/ml",
  "name_fr": "Alomide 1.78 mg/ml",
  "name_nl": "Alomide 1.78 mg/ml",
  "amp_code": "SAM153937-00",
  "strengths": [
    "1.7800",
    "0.0700",
    "0.1000",
    "47.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Lodoxamide Tromethamine",
    "Benzalkonium Chloride",
    "Disodium Edetate",
    "Mannitol",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Lodoxamide",
  "authorisation_numbers": [
    "BE153937"
  ]
}
API referenceMCP serverPlans

See everything about lodoxamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console